PD‐L1 is an important factor for poor prognosis in patients with lung adenocarcinoma.7 Furthermore, PD‐L1 higher expression of carcinoma cells has been shown to be connected with a better immunological response after checkpoint blockade. This evidence concerns the gene CD274 and lung adenocarcinoma.